BioHealth News Archive

Here’s Why Alexandria Real Estate Outperformed Its Peers During the COVID-19 Pandemic | The Motley Fool

Here’s Why Alexandria Real Estate Outperformed Its Peers During the COVID-19 Pandemic | The Motley Fool

Office real estate investment trusts (REITs) have been under pressure for the past year. The coronavirus pandemic has caused some investors to even question…

Read More
Virginia Governor Ralph Northam – May

Virginia Governor Ralph Northam – May

PETERSBURG—Governor Ralph Northam today announced that AMPAC Fine Chemicals (AFC), a leading manufacturer of Active Pharmaceutical Ingredients (APIs) in the United States, will invest…

Read More
Lab on a Chip – Devices and applications at the micro- and nanoscale

Lab on a Chip – Devices and applications at the micro- and nanoscale

Barrier function of epithelia is crucial for maintaining homeostasis in the human body. Its disruption in organs such as the intestine, kidney, lung, skin,…

Read More

In Conversation: Sarah Miller, Vice President of Economic Development, BioHealth Innovation, Inc. · BioBuzz

After spending the past five years fostering economic development in Montgomery County, Sarah Miller is turning her attention to the biopharma industry and the…

Read More
We’re Open for Business! A First Sneak Peek of JLABS @ Washington, DC – Blog Post | JLABS (2)

We’re Open for Business! A First Sneak Peek of JLABS @ Washington, DC – Blog Post | JLABS (2)

Johnson & Johnson Innovation – JLABS @ Washington, DC: We did it! Persevering through a time of great challenge and change, today we’re happy…

Read More
Gain Therapeutics Presents Positive In Vitro & In Vivo Data on Its Orally Bioavailable Brain Penetrant Star Compounds for the Treatment of GBA1 Parkinson’s Disease & Related α-synucleopathies at the XXVI IAPRD World Congress

Gain Therapeutics Presents Positive In Vitro & In Vivo Data on Its Orally Bioavailable Brain Penetrant Star Compounds for the Treatment of GBA1 Parkinson’s Disease & Related α-synucleopathies at the XXVI IAPRD World Congress

BETHESDA, Md., May 03, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”), a biotechnology company focused on redefining drug discovery by using…

Read More
Sound Off and Save the Date – Women Building Bio Virtual Conference on September 30, 2021!

Sound Off and Save the Date – Women Building Bio Virtual Conference on September 30, 2021!

Women Building Bio 2021 is just around the corner. Save the date for September 30th to join our 6th year of Women Building Bio.…

Read More
Emergent BioSolutions ‘hopeful’ to return to vaccine production, plans to respond to FDA ‘within days’ – Washington Business Journal

Emergent BioSolutions ‘hopeful’ to return to vaccine production, plans to respond to FDA ‘within days’ – Washington Business Journal

On a first-quarter earnings call Thursday, Emergent's CEO addressed a turbulent month for the Gaithersburg biopharmaceutical company. Image: https://www.bizjournals.com {iframe}https://www.bizjournals.com/washington/news/2021/04/29/emergent-biosolutions-to-submit-response-to-fda.html{/iframe}

Read More
Largest Bioscience Employers in Greater D.C. – Washington Business Journal

Largest Bioscience Employers in Greater D.C. – Washington Business Journal

Locally Researched by: Carolyn M. Proctor, Washington Business Journal Apr 30, 2021, 6:00am EDT Source: The companies, Form 990s, SEC filings and regional economic…

Read More
Maryland’s biggest VC funding quarter in 20 years brought $560M to startups – Technical.ly Baltimore

Maryland’s biggest VC funding quarter in 20 years brought $560M to startups – Technical.ly Baltimore

Around Baltimore, folks tend to analyze economic trends through three vantage points: the city, the region and the state. No matter which level you’re…

Read More
How Novavax went from near collapse to potential Covid vaccine powerhouse – Washington Business Journal

How Novavax went from near collapse to potential Covid vaccine powerhouse – Washington Business Journal

A potential vaccine has brought new life to the embattled Gaithersburg biotech. Image: Novavax CEO Stanley Erck, left, and Gregory Glenn, head of research…

Read More
Vaccitech Announces Pricing of Initial Public Offering – Vaccitech

Vaccitech Announces Pricing of Initial Public Offering – Vaccitech

Oxford, UK – Vaccitech plc (“Vaccitech”) (Nasdaq: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for…

Read More
Gain Therapeutics CEO Eric Richman Guests on BioTalk

Gain Therapeutics CEO Eric Richman Guests on BioTalk

Gain Therapeutics CEO Eric Richman joins BioTalk to Discuss His Career, Redefining Drug Discovery, and Ventures in the BioHealth Capital Region and Beyond. Listen…

Read More
The Immunology Capital Next to the Nation’s Capital in Maryland

The Immunology Capital Next to the Nation’s Capital in Maryland

This is a complimentary webinar - the optional attendee list is $39. For registration questions, please email Elizabeth Baker at liz.baker@bisnow.com What You'll Learn: …

Read More
George Mason University incoming executive André Marshall on innovation, tech workforce – Washington Business Journal

George Mason University incoming executive André Marshall on innovation, tech workforce – Washington Business Journal

André Marshall will draw from his life experience across innovation and workforce development to drive Mason to new heights, he says. Image: Andre Marshall,…

Read More